After the great success of the first two events, Rentschler Biotechnologie GmbH was delighted to announce the third Laupheimer Zelltage, this time focusing on "Processes for Virus-based Biologics".

The scientific program encompassed all aspects related to platform technologies for the manufacturing and control of viral biopharmaceuticals, including viral vectors, oncolytic viruses and virus-based vaccines.

This third industrial cell culture conference brought together international academic and industrial experts in cell culture and process technology for the production of virus-based biologics. It was the first conference of its type, and was eagerly awaited by the scientific and industrial community.